Long-term safety and effectiveness of dupilumab in patients with severe asthma: data from post-marketing surveillance in Japan

Authors

Institutions

Publication Details

Journal
Respiratory Investigation
Published
2025-06-27
DOI
https://doi.org/10.1016/j.resinv.2025.05.015
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term safety and effectiveness of dupilumab in patients with severe asthma: data from post-marketing surveillance in Japan

Mami Orimo, Makoto Nagata, Masato Ishida, Ryo Yamaguchi et al.
Respiratory Investigation
Asthma and respiratory diseases
article

Long-term safety and effectiveness of dupilumab in patients with severe asthma: data from post-marketing surveillance in Japan

Mami Orimo, Makoto Nagata, Masato Ishida, Ryo Yamaguchi, Makiko Usami
article en

Abstract

No abstract available for this paper.
Respiratory InvestigationVol. 63(5)
Saitama Medical University Hospital (JP), Tokyo Metropolitan Board of Education (JP)
Sanofi K.K.
Openalex Percentile: Top 80%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.